Biomarker may predict patient outcomes
Xổ số miền bắc thứ 4 hàng tuầnBy analyzing variations in the level of human papillomavirus (HPV) in head and neck cancers, researchers at The University of Texas MD Anderson Cancer Center have discovered a gene signature associated with treatment response and survival in patients. Rather than simply classifying tumors as HPV-positive or HPV-negative, this biomarker may one day enable clinicians to better predict patient outcomes, ultimately allowing for reduced treatment intensity to minimize severe side effects.